SCHEMBL19080029

SCHEMBL19080029

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5c(ccc6c5oc5c7ccccc7c7ccccc7c65)c4)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.38
CDC25A P30304 1/20 0.38
CDC25C P30307 1/20 0.38
CYP1A1 P04798 10/20 0.36
CYP1B1 Q16678 10/20 0.36
CYP1A2 P05177 10/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2B6 P20813 2/20 0.36
CYP2C19 P33261 2/20 0.36
ABCG2 Q9UNQ0 2/20 0.36
PRKDC P78527 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PDE5A O76074 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
ABCB1 P08183 1/20 0.36
MAPT P10636 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080026 0.93 ARSA (0.42) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19080092 0.91 CYP1A1 (0.42) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19080023 0.90 CYP1A1 (0.46) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19079927 0.90 ESR1 (0.43) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19080060 0.89 ARSA (0.43) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19080050 0.88 CYP1A1 (0.40) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL22260282 0.88 ESR1 (0.44) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19076394 0.87 ALOX5 (0.39) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19080090 0.87 CYP1A1 (0.43) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19080032 0.85 CDK1 (0.33) ARSACDC25ACDC25CGPR84CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ARSA 4452/4885CDC25A 44/4885CDC25C 132/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ARSA 4452/4885CDC25A 44/4885CDC25C 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.